Pesquisas alternativas:
drug disease » drug release (Expandir a Pesquisa)
drug codes » drug code (Expandir a Pesquisa), drug comes (Expandir a Pesquisa), drug copies (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug diet » drugs diet (Expandir a Pesquisa), drug does (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
drug codes » drug code (Expandir a Pesquisa), drug comes (Expandir a Pesquisa), drug copies (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug diet » drugs diet (Expandir a Pesquisa), drug does (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa)
201
Por Deshayes, Emmanuel, Roumiguie, Mathieu, Thibault, Constance, Beuzeboc, Philippe, Cachin, Florent, Hennequin, Christophe, Huglo, Damien, Rozet, François, Kassab-Chahmi, Diana, Rebillard, Xavier, Houédé, Nadine
Publicado no Drug Des Devel Ther (2017)
“...Prostate cancer is the most common malignant disease in men. Several therapeutic agents have been...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
202
Por Lorusso, Domenica, Tripodi, Elisa, Maltese, Giuseppa, Lepori, Stefano, Sabatucci, Ilaria, Bogani, Giorgio, Raspagliesi, Francesco
Publicado no Drug Des Devel Ther (2018)
“... of death among gynecological malignancies. Most of the patients present recurrent disease and unfortunately...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
203
“... are reviewed. SUMMARY: Azacitidine is the first drug FDA-approved for the treatment of myelodysplastic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
204
“... of estrogen signaling, the poorer is the prognosis of the disease. De novo or acquired antiestrogen resistance...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
205
Por Helmschrott, Matthias, Rivinius, Rasmus, Bruckner, Thomas, Katus, Hugo A, Doesch, Andreas O
Publicado no Drug Des Devel Ther (2017)
“... and by estimated glomerular filtration rate (eGFR) calculated from Modification of Diet in Renal Disease equation...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
206
“... the core pathways reproducibly shown to lead the development and progression of this disease, DNA repair...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
207
Por Hemn, Hassan Othman, Noordin, Muhammad Mustapha, Rahman, Heshu Sulaiman, Hazilawati, Hamza, Zuki, Abubakr, Chartrand, Max Stanley
Publicado no Drug Des Devel Ther (2015)
“... in the plaque size in ZER-medicated aortas. On the other hand, dietary supplementation of ZER for almost 10...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
208
“.... Currently, there is no US Food and Drug Administration-approved treatment for AA. Many off-label treatments...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
209
Por Milic, Sandra, Mikolasevic, Ivana, Krznaric-Zrnic, Irena, Stanic, Marija, Poropat, Goran, Stimac, Davor, Vlahovic-Palcevski, Vera, Orlic, Lidija
Publicado no Drug Des Devel Ther (2015)
“...Diet and lifestyle changes have led to worldwide increases in the prevalences of obesity...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
210
“... in the disease development. Here, we investigated whether INT-767, the newly-identified dual FXR/TGR5 agonist...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
211
“... mononitriles 4a–e via a direct reaction with lithium bis(trimethylsilyl)amide LiN(TMS)(2) followed by de...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
212
Por Gu, Namyi, Cho, Joo-Youn, Shin, Kwang-Hee, Jang, In-Jin, Rhee, Moo-Yong
Publicado no Drug Des Devel Ther (2016)
“... (300 mEq/day) for 7 days in the first hospitalization period and the other diet in the second period...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
213
Por Muratore, Maurizio, Quarta, Eugenio, Grimaldi, Antonella, Calcagnile, Fabio, Quarta, Laura
Publicado em 2011
“... better tolerated than other bisphosphonates and free of high-risk contraindications. Specifically...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
214
Por Zhu, Juanjuan, Ren, Tingting, Zhou, Mingyu, Cheng, Mingliang
Publicado no Drug Des Devel Ther (2016)
“... group (CG). AFLD mice models were established with Lieber–DeCarli ethanol diet and evenly assigned...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
215
Por Zhu, Pei-Li, Pan, Si-Yuan, Zhou, Shu-Feng, Zhang, Yi, Wang, Xiao-Yan, Sun, Nan, Chu, Zhu-Sheng, Yu, Zhi-Ling, Ko, Kam-Ming
Publicado no Drug Des Devel Ther (2015)
“...BACKGROUND: Currently, combined therapy using herbs and synthetic drugs has become a feasible...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
216
Por Warnke, Clemens, Wiendl, Heinz, Hartung, Hans-Peter, Stüve, Olaf, Kieseier, Bernd C
Publicado em 2010
“...Orally available disease-modifying drugs for relapsing-remitting multiple sclerosis (MS) represent...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Artigo
217
Por Kraeuter, Maximilian, Helmschrott, Matthias, Erbel, Christian, Gleissner, Christian A, Frankenstein, Lutz, Schmack, Bastian, Ruhparwar, Arjang, Ehlermann, Philipp, Katus, Hugo A, Doesch, Andreas O
Publicado em 2013
“... regarding the Modification of Diet in Renal Disease or hematological parameters were seen (all P...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
218
Por Chimenti, Maria Sole, Saraceno, Rosita, Chiricozzi, Andrea, Giunta, Alessandro, Chimenti, Sergio, Perricone, Roberto
Publicado em 2013
“... increases the half-life of CZP and confers to the drug a unique structure that differs from the other anti...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
219
“... complex signaling networks that underlie tumorigenesis and disease progression. This review describes...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
220
Por Zhang, Mingyan, Yan, Zhibin, Bu, Lili, An, Chunmei, Wang, Dan, Liu, Xin, Zhang, Jianfeng, Yang, Wenle, Deng, Bochuan, Xie, Junqiu, Zhang, Bangzhi
Publicado no Drug Des Devel Ther (2018)
“... is the major cause of end-stage renal disease. Current therapeutic strategies slow down but cannot reverse...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo